Skip to main content

Health condition

PKAN and NBIA disorders

Neurodegeneration with brain iron accumulation (NBIA) covers rare genetic conditions, including PKAN, in which iron deposits in deep brain structures cause progressive movement problems.

Key points

What matters most, at a glance.

The essentials in plain English - symptoms, when to seek help, who to see and what treatment looks like.

  • PKAN (PANK2 gene) is the most common NBIA disorder, usually beginning with dystonia in childhood or adolescence

  • Adult-onset and slower atypical forms exist and are often misdiagnosed for years

  • MRI shows a characteristic eye-of-the-tiger sign in the globus pallidus in PKAN

  • Genetic panels covering NBIA genes establish the precise subtype

  • Treatment is symptom-focused: dystonia management, including deep brain stimulation in selected people

  • Specialist movement disorder centres and patient registries offer access to research

Understanding it

About PKAN and NBIA disorders, and what to do next.

The NBIA family - PKAN, PLAN, MPAN, BPAN and others - shares a common thread: iron accumulation in the basal ganglia driving progressive dystonia, parkinsonism, spasticity and, in some forms, cognitive or psychiatric change. Classic PKAN starts in childhood, but atypical PKAN and several other NBIA disorders present in adolescence or adult life with speech disturbance, gait dystonia or neuropsychiatric features, and often carry a long trail of misdiagnosis.

MRI is the pivotal clue - patterns of iron deposition, including PKAN’s eye-of-the-tiger sign - followed by genetic testing to pin down the subtype, which matters for prognosis and family counselling. There is no cure, and iron-chelation trials have been mixed, so care focuses on what demonstrably helps: botulinum toxin and medication for dystonia, deep brain stimulation in carefully selected patients, and multidisciplinary therapy input. These are conditions for specialist movement disorder centres; a referral there, supported by patient organisations for the NBIA disorders, connects families to expertise and ongoing research.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them.

Frequently asked

Common questions about PKAN and NBIA disorders.

Quick, plain-English answers to what people ask us most.

  • What are PKAN and NBIA disorders?

    PKAN (pantothenate kinase-associated neurodegeneration) is the most common type of NBIA (neurodegeneration with brain iron accumulation), a group of rare inherited conditions causing abnormal iron build-up in specific brain regions, leading to progressive movement and neurological problems.

  • What causes PKAN and NBIA disorders?

    These are genetic conditions caused by mutations in specific genes involved in cellular processes; PKAN specifically results from mutations in the PANK2 gene, disrupting normal cell metabolism and leading to iron accumulation in the brain.

  • What are the symptoms?

    Progressive difficulty with movement and coordination, muscle stiffness or spasticity, involuntary movements, and, over time, cognitive changes are typical, with earlier onset generally associated with faster progression.

  • Are PKAN and NBIA disorders serious?

    Yes, these are serious, progressive neurological conditions, particularly the earlier-onset forms, though the rate of progression and severity vary considerably between individuals and specific NBIA subtypes.

  • Are PKAN and NBIA disorders hereditary?

    Yes, these are inherited genetic conditions, most commonly in an autosomal recessive pattern, meaning both parents typically carry one copy of a faulty gene without being affected themselves.

  • Can PKAN and NBIA disorders be treated?

    There's no cure currently, but treatment focuses on managing symptoms, including medications for muscle stiffness and movement problems, physiotherapy, and supportive care, with research ongoing into disease-modifying treatments.

  • How are PKAN and NBIA disorders diagnosed?

    MRI brain imaging showing characteristic patterns of iron accumulation, combined with genetic testing to confirm the specific underlying gene mutation, establishes the diagnosis.

  • How does the disease progress over time?

    Progression varies by subtype and age of onset, with earlier-onset forms generally progressing more quickly; regular specialist follow-up helps track changes and adjust supportive treatment over time.

  • PKAN vs other NBIA subtypes — what's the difference?

    PKAN is the most common and best-characterised NBIA subtype, but several other genetic forms exist, each with slightly different patterns of onset and symptoms; genetic testing identifies the specific subtype, which can guide prognosis discussions.

  • When should I see a specialist, and how quickly can I be seen privately?

    See a neurologist promptly if there are progressive movement or coordination symptoms in a child or young adult, particularly with a family history. Private specialist and genetic assessment is typically available within about two weeks, considerably faster than standard NHS pathways for rare disease referral.